SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-035145
Filing Date
2022-03-18
Accepted
2022-03-17 17:40:43
Documents
14
Period of Report
2022-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm229587d1_8k.htm   iXBRL 8-K 26052
2 EXHIBIT 99.1 tm229587d1_ex99-1.htm EX-99.1 40725
6 GRAPHIC tm229587d1_ex99-1img01.jpg GRAPHIC 15688
  Complete submission text file 0001104659-22-035145.txt   273358

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lqda-20220317.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lqda-20220317_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lqda-20220317_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT tm229587d1_8k_htm.xml XML 3683
Mailing Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709
Business Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 22750077
SIC: 2834 Pharmaceutical Preparations